Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_assertion type Assertion NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_head.
- NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_assertion description "[Mechanistic investigations suggested a potent antiproliferative, proapoptotic effect of the nanodrug in the metastatic cells, potentiated by a cell-cycle arrest produced by administration of the low-dose anthracycline. miR-10b was overexpressed specifically in cells with high metastatic potential, suggesting a role for this miRNA as a metastasis-specific therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_provenance.
- NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_assertion evidence source_evidence_literature NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_provenance.
- NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_assertion SIO_000772 26359455 NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_provenance.
- NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_assertion wasDerivedFrom befree-2016 NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_provenance.
- NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_assertion wasGeneratedBy ECO_0000203 NP1293973.RAkYNVhmnW5QoTi3L1ytFDn5lvG3q10Jc0ZX-HbGOXk6o130_provenance.